コンテンツへスキップ
Merck
  • A lufenuron pre-treatment may enhance the effects of enilconazole or griseofulvin in feline dermatophytosis?

A lufenuron pre-treatment may enhance the effects of enilconazole or griseofulvin in feline dermatophytosis?

Journal of feline medicine and surgery (2008-08-08)
Francesca Mancianti, Sara Dabizzi, Simona Nardoni
要旨

The effectiveness of enilconazole (4 weekly rinses with a 0.2% solution) or griseofulvin (50mg/kg twice daily for 40 days) following a pre-treatment with oral lufenuron (100mg/kg by-weekly for 8 weeks) was tested on 25 (11+14) Microsporum canis infected cats. Control animals were treated with lufenuron, griseofulvin and enilconazole alone. At day 150 pre-treated animals were culturally negative and clinically cured. While lufenuron alone was found to be ineffective against M canis infection, an immunomodulatory effect of the drug can be suggested, as reported in literature. Its use could be reserved to long-lasting infections, unsuccessfully treated with conventional drugs. Further studies are required to clearly establish the possible adjuvant effect of this molecule when used prior to enilconazole or griseofulvin.

材料
製品番号
ブランド
製品内容

Supelco
ルフェヌロン, PESTANAL®, analytical standard
ルフェヌロン, European Pharmacopoeia (EP) Reference Standard
ルフェヌロン, European Pharmacopoeia (EP) Reference Standard